Artisan Pharma gets $39 million in financing

Artisan Pharma Inc., a four-person Framingham company, said today it had won $39 million in venture-capital financing to develop a Japanese company's experimental drug to reduce blood clotting and inflammation. The drug, made by Asahi Kasei Pharma Corp., is awaiting approval in Japan.

Artisan, formed by venture investors a month ago to license the drug from AKP, plans to hire several employees and begin conducting clinical trials in the United States starting next year.
(By Stephen Heuser, Globe staff)

•  Previous Entry
• Next Entry